MedPath

A study to assess the usefulness of various tests done for the monitoring of long term complications in survivors of leukemia and lymphoma.

Not Applicable
Registration Number
CTRI/2019/06/019880
Lead Sponsor
Tata Memorial Centre Research Administrative council
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients previously treated for acute leukemia and lymphoma that are in complete remission.

2. Age more than or equal to 15 years at the time of inclusion into the study.

3. Those that have completed at least 2 years since their last therapy.

4. Willing to follow up at Tata Memorial Center, Mumbai.

Exclusion Criteria

Those that have undergone or are planned for hematopoietic stem cell transplant.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath